Therefore, we evaluated the inhibitory properties of four phytochemicals, isoliquiritigenin, shogaol, tehranolide, and theophylline, against AKT1, a cancer therapeutic molecular target, using molecular docking. The gene discussed is AKT1; the disease is cancer.